Filing Details

Accession Number:
0001325447-12-000038
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-11-02 13:49:43
Reporting Period:
2012-11-01
Filing Date:
2012-11-02
Accepted Time:
2012-11-02 13:49:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1459450 Myrexis Inc. MYRX Pharmaceutical Preparations (2834) 263996918
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1325447 First Eagle Investment Management, Llc 1345 Avenue Of The Americas
New York NY 10105
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.01 Par Value (The "Common Stock") Disposition 2012-11-01 35,000 $2.37 2,713,617 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
Footnotes
  1. The shares of Common Stock reported herein are indirectly beneficially owned by First Eagle Investment Management, LLC, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940 ("FEIM"). FEIM is a subsidiary of Arnhold and S. Bleichroeder Holdings, Inc. The shares are held by various clients in accounts under FEIM's management and control. FEIM disclaims beneficial ownership of the shares of Common Stock as provided in Rule 16a-1 and otherwise to the extent such beneficial ownership exceeds its pecuniary interest therein.